Celemics, Inc. (KOSDAQ:331920)

South Korea flag South Korea · Delayed Price · Currency is KRW
5,080.00
+120.00 (2.42%)
At close: Mar 6, 2026
59.75%
Market Cap 41.47B
Revenue (ttm) 6.13B
Net Income (ttm) -12.56B
Shares Out 8.16M
EPS (ttm) -1,539.90
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 105,333
Average Volume 645,411
Open 4,965.00
Previous Close 4,960.00
Day's Range 4,765.00 - 5,150.00
52-Week Range 2,535.00 - 5,500.00
Beta 1.02
RSI 62.48
Earnings Date Mar 20, 2026

About Celemics

Celemics, Inc. designs, manufactures, and distributes sequencing kits in South Korea. The company offers whole exome sequencing panels; NGS target enrichment panels; customized and ready-to-use enrichment panels; and modular accessories, including library preparation kits, double standard Cdna synthesis, hybridization enhancer, celan-up and streptavidin beads, CeleNM beads, and polymerase. It also provides celemics analysis, whole exome sequencing, customized NGS panels, sequencing, bioinformatics, biopharma, and custom NGS assay development se... [Read more]

Industry Surgical and Medical Instruments and Apparatus
Founded 2010
Employees 40
Stock Exchange KOSDAQ
Ticker Symbol 331920
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.